Related Experiment Video
Updated: Jul 14, 2026
07:15
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
[New perspectives in long QT syndrome].
Argelia Medeiros-Domingo1, Pedro Iturralde-Torres, Samuel Canizales-Quinteros
1Unidad de Biología Molecular y Medicina Genómica, Instituto de Investigaciones Biomédicas. argeliamed@yahoo.com
Summary
Long QT Syndrome (LQTS), a cardiac channelopathy, involves prolonged heart repolarization and sudden death risk. Advances in genetic understanding improve risk stratification and treatment for this condition.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Context:
- Long QT Syndrome (LQTS) is a primary cardiac channelopathy.
- Characterized by prolonged ventricular repolarization, increasing sudden death risk from arrhythmias.
- LQTS is the first described cardiac channelopathy and remains well-understood.
Purpose:
- To provide an overview of recent advancements in Long QT Syndrome (LQTS) knowledge.
- Highlighting progress in genotype-phenotype correlations and genetic-guided treatments.
- Discussing the increased prevalence and ethnic-specific genetic factors in LQTS.
Summary:
- Significant progress has been made in understanding LQTS, with eight genes identified.
- Genotype-phenotype correlations have improved risk stratification and treatment strategies.
- Genetic screening reveals LQTS is more common than previously thought, with ethnic variations influencing drug-induced QT prolongation.
Impact:
- Improved understanding of LQTS molecular basis aids in developing safer drugs and managing arrhythmias.
- Genetic screening and tailored treatments enhance patient risk stratification and outcomes.
- Identifies ethnic-specific polymorphisms increasing susceptibility to drug-induced QT prolongation, addressing a public health concern.
Related Concept Videos
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
01:28Mechanism of Cardiac Arrhythmias
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
01:19Electrophysiology of Normal Cardiac Rhythm
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase of...
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...